Sort by
Keyphrases
Multiple Myeloma
100%
African American Patients
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Prolonged Response
100%
African American
50%
Disease Stage
12%
Consecutive Patients
12%
Patient Demographics
12%
Overall Survival
12%
High Mortality
12%
Cytogenetic Abnormalities
12%
Working Diagnosis
12%
Event-free Survival
12%
Complete Response
12%
Induction Chemotherapy
12%
Albumin
12%
Partial Response
12%
Relapse Rate
12%
Blood Levels
12%
Plasma Cells
12%
β2-microglobulin (β2-MG)
12%
Age-stage
12%
Blood Plasma
12%
Marrow Infiltration
12%
Great Events
12%
Intensified Chemotherapy
12%
Immunology and Microbiology
Multiple Myeloma
100%
Autologous Stem Cell Transplantation
100%
Blood Plasma
20%
Overall Survival
20%
Immunoglobulin Producing Cell
20%
Event Free Survival
20%
Albumin Blood Level
20%
Biochemistry, Genetics and Molecular Biology
Autologous Stem Cell Transplantation
100%
Cytogenetics
20%
Overall Survival
20%
Event Free Survival
20%
Microglobulin
20%
Albumin Blood Level
20%
Blood Plasma
20%
Immunoglobulin Producing Cell
20%
Neuroscience
Stem Cell
100%
Serum Albumin
20%
Cytogenetics
20%
Immunoglobulin Producing Cell
20%